1300 Participants Needed

ePRO Monitoring for Chronic Disease Care Transitions

Recruiting at 1 trial location
SP
AD
Overseen ByAnuj Dalal, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Brigham and Women's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a digital health app (ePRO Application) designed to help manage symptoms after hospital discharge for individuals with multiple chronic conditions. The app aims to detect early warning signs of health issues and alert medical teams to prevent complications. Participants will receive either standard care or use the app to determine if it reduces post-discharge problems. Individuals who have stayed in the hospital for over a day and have conditions like asthma, diabetes, or heart disease might be suitable candidates. As an unphased trial, this study offers a unique opportunity for patients to contribute to innovative healthcare solutions and potentially improve their own post-discharge outcomes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this ePRO Application is safe for use in chronic disease care transitions?

Research has shown that using the ePRO App for real-time symptom tracking appears promising. Studies have found that electronic patient-reported outcomes (ePROs) can help reduce issues during changes in care. When patients use the app to report symptoms, doctors can quickly identify and address any problems.

The system's safety seems reliable. Patients have used similar tools without major issues. Although specific safety data for the ePRO App itself is not available, electronic monitoring in healthcare has generally been well-received.

For those considering joining a trial that uses ePRO, the app is designed to catch problems early and improve patient care. Safety reports so far suggest it is a low-risk addition to healthcare routines.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores the use of an ePRO (electronic Patient-Reported Outcomes) application to enhance chronic disease care transitions. Unlike traditional care, which often relies on periodic in-person visits, this approach leverages digital technology to continuously collect patient data in real-time. This method could lead to more personalized and timely interventions, potentially improving patient outcomes and reducing adverse events after discharge. By integrating patient-reported information seamlessly into the care process, this trial aims to innovate how healthcare providers monitor and respond to chronic disease management.

What evidence suggests that the ePRO Application is effective for minimizing post-discharge adverse events in patients with multiple chronic conditions?

Research has shown that the ePRO (electronic Patient-Reported Outcome) app, which participants in this trial may use, improves patient care by tracking symptoms in real-time. Studies have found that ePRO tools enable patients to report symptoms quickly and accurately. This leads to faster responses from healthcare providers, potentially reducing complications after hospital discharge. ePRO systems are particularly useful for managing long-term conditions by providing timely and detailed patient feedback. This feedback aids doctors in making better decisions and adjusting treatments as needed. Overall, early findings suggest that ePRO enhances patient monitoring and safety during changes in care.16789

Who Is on the Research Team?

AD

Anuj K Dalal, MD

Principal Investigator

Brigham and Women's Hospital

Are You a Good Fit for This Trial?

This trial is for adults with two or more chronic conditions like heart disease, diabetes, COPD, etc., who are hospitalized and will be discharged to home or a facility. They must speak English or have an English-speaking healthcare proxy.

Inclusion Criteria

I have two or more chronic conditions from a specified list.
Non-English-speaking patients who have an English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
I or my healthcare proxy can communicate in English.
See 2 more

Exclusion Criteria

No identifiable healthcare proxy or next of kin (i.e., a family caregiver)
Less than two chronic conditions
I was in the hospital for less than a day.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Pre-implementation

Development and validation of a predictive model of post-discharge AEs for MCC patients using PRO questionnaires and EHR-derived variables

18 months

Main Trial (RCT) Period

Randomized controlled trial comparing real-time symptom monitoring intervention to usual care for patients with MCCs transitioning out of the hospital

30 months

Follow-up

Participants are monitored for safety and effectiveness after discharge, focusing on adverse events and healthcare utilization

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • ePRO Application
Trial Overview The study tests an ePRO application designed to monitor symptoms in real-time and predict adverse events after patients with multiple chronic conditions leave the hospital. It involves developing predictive models and integrating them into digital health apps.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Arm 3)Experimental Treatment1 Intervention
Group II: Usual Care (Arm 1)Active Control1 Intervention
Group III: Usual Care (Arm 2)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+

RAND

Collaborator

Trials
145
Recruited
617,000+

Published Research Related to This Trial

Older adults with multiple chronic conditions and their families emphasized the importance of being actively involved in managing their care transitions, highlighting that engagement can improve their experiences and outcomes.
The study identified key areas for improvement in care transitions, including enhancing support for person- and family-centered care, ensuring active engagement of older adults and families, and providing better resources to navigate transitions effectively.
Use of participatory visual narrative methods to explore older adults' experiences of managing multiple chronic conditions during care transitions.Backman, C., Stacey, D., Crick, M., et al.[2019]
A study involving 38 hospital-based professionals identified multiple hazards to medication safety for older adults during care transitions, highlighting issues such as complex dosing and knowledge gaps in medication management.
The research revealed that medication-related harms stem from both hospital work systems and challenges faced at home, emphasizing the need for improved communication and support for patients and caregivers post-discharge.
Understanding Hazards for Adverse Drug Events Among Older Adults After Hospital Discharge: Insights From Frontline Care Professionals.Xiao, Y., Smith, A., Abebe, E., et al.[2023]
The electronic medication reconciliation module significantly improved the accuracy of identifying and resolving medication discrepancies compared to the traditional paper-based method, with participants leaving fewer discrepancies unaddressed (0.45 vs. 1.55 discrepancies).
Although the electronic system did not reduce the time taken for reconciliation, it was highly rated for usability, with 17 out of 19 physicians preferring it over the paper method, indicating a positive reception for future integration into electronic medical records.
Evaluation of an Electronic Module for Reconciling Medications in Home Health Plans of Care.Kramer, HS., Gibson, B., Livnat, Y., et al.[2018]

Citations

Assessing the Implementation and Effectiveness of ...This study aims to evaluate the implementation and effectiveness of the electronic Patient-Reported Outcome (ePRO) mobile app and portal system.
Real‐time symptom monitoring using electronic patient ...Real-time symptom monitoring using electronic patient-reported outcomes: A prospective study protocol to improve safety during care transitions ...
Electronic Collection of Patient-Reported Outcomes to ...We define kidney ePRO systems as ambulatory, noninvasive digital technologies that enable people with kidney disease to report and record PRO data ...
Electronic Patient Reported Outcome (ePRO) Mobile ...Surveys capture patient demographics, assessment of quality-of-life, chronic disease management, primary care experience, and Electronic Patient Reported ...
Electronic Patient-Reported Outcome–Based Interventions ...We performed a systematic and mapping review of the scientific literature on the current ePRO-based approaches used for palliative cancer care.
Real-Time Symptom Monitoring Using ePROs to Prevent ...Using real-time patient-reported outcomes of hospitalized patients has the potential to reduce adverse events during care transitions.
ePRO TransitionsThe app will collect patient-reported outcomes (PROs) and provide personalized AE risk assessments by integrating PROs with electronic health record (EHR) data.
8.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39956797/
Real-time symptom monitoring using electronic patient ...Real-time symptom monitoring using electronic patient-reported outcomes: A prospective study protocol to improve safety during care transitions ...
Real-time Symptom Monitoring Using ePROs to Prevent ...This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security